The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides. In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.
The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.
The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.
The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.
The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.
|
|
|
All reports in Biotechnology
|
China Pharmaceutical & Biotechnology Monthly
periodical | published by: General Biologic Group Ltd.
... opportunities and challenges China presents. Its contents include top stories, key facts and figures, news in general, policy and regulations, investments and finance, company, trade, research & development and IP & legal. It also has ...
|
more...
|
$2,400.00
|
|
Value-Added Produce
4/1/1995 | published by: Kalorama Information
... is value-added. Examines demand and supply in the market; product innovations; technological developments in packaging, sanitation, refrigeration, and category management; and the globalization of the produce industry. Consumer demographic trends are analyzed, and leading national ...
|
more...
|
$1,625.00
|
|
Market For Monoclonal Antibodies [MABs]
7/1/1995 | published by: Kalorama Information
... critical role MABs will play in the future. Explains which new MABs will be instrumental in treating organ transplants, cancer, sepsis, infectious diseases, and sexually transmitted diseases. Covers new developments in diagnostic MABs that will ...
|
more...
|
$1,625.00
|
|
Market For Gene Therapy and Antisense Drugs
8/1/1995 | published by: Kalorama Information
... $60 billion in 2005. This report from Kalorama Information examines the advantages and disadvantages of the various types of gene therapy and assesses which technologies and companies are likely to lead the market. Examines the ...
|
more...
|
$1,625.00
|
|
Market for Bioremediation Products and Services
9/1/1995 | published by: Kalorama Information
... and processes, the regulatory and legislative environment, alternative remediation cost/benefit comparisons, potential sites for bioremediation, and new product advances through genetic engineering. Important end-use markets are thoroughly evaluated and trends in international markets are analyzed. ...
|
more...
|
$1,625.00
|
|
Vaccines: World Market
10/1/1995 | published by: Kalorama Information
... to the future of disease prevention. Also details the life-saving potential of therapeutic vaccines (theraccines) for treating cancer, AIDS, autoimmune diseases and diabetes. Forecasts sales for those products in development; discusses what role key companies ...
|
more...
|
$1,625.00
|
|
Market for Antiviral Therapeutics and Vaccines
1/1/1996 | published by: Kalorama Information
... rubella vaccines; polio vaccines; respiratory syncytial virus therapeutics; and products used to treat rare diseases. Offers historical information for the past 5 years and forecasts for the next 5 years. Profiles include established and emerging ...
|
more...
|
$1,625.00
|
|
Market for Healthy Prepared Foods
2/1/1996 | published by: Kalorama Information
... 1995 and provides forecasts through 2000. You'll find complete overviews of the changing consumer environment, opportunities for food producers and marketers, and a discussion of various distribution channels. You'll also get detailed profiles of such ...
|
more...
|
$1,625.00
|
|
Market For Cancer Diagnostics
4/1/1996 | published by: Kalorama Information
... in years ahead. All aspects of this important area are detailed here: the new products, industry mergers, the regulatory environment, demographic data, market share and forecast data, new technologies, and more. Company profiles are included.
|
more...
|
$1,625.00
|
|
Cancer Therapeutics Market
5/1/1996 | published by: Kalorama Information
... agents, cancer vaccines, genetic therapies, and other emerging technologies. Find out about strategies companies are using to extend the life span of brand-name cancer therapeutic products that are coming off patent. Leading players are profiled.
|
more...
|
$812.00
|
|
Market for Genitourinary Pharmaceuticals
10/1/1996 | published by: Kalorama Information
... silence, are driving the development of innovative pharmacological solutions to these age-related problems. Also, will biotechnology produce a treatment for genitourinary cancers? This Kalorama Information report explores these issues and more. The major companies competing ...
|
more...
|
$1,625.00
|
|
The Market for Immunomodulators
2/1/1997 | published by: Kalorama Information
... for current market revenues and forecasts are reported for prescription immunomodulator products used in the United States, with additional sections providing an overview of the international market on a country-by-country or regional basis. The report ...
|
more...
|
$1,625.00
|
|
Global Biotechnology Product Registration: E.U., U.S., and Japan
3/1/1997 | published by: Barnett Educational Services
... medicines -- the U.S. E.U., and Japan. Within these three "prize" markets, historic and fundamental regulatory changes affecting biotechnology product regulation have been implemented recently. In the United States, the FDA has just implemented a ...
|
more...
|
$245.00
|
|
Biotech Revolution, The (Technical Insights)
1/1/1998 | published by: Frost & Sullivan
... market sectors. Research at facilities at the forefront of R&D is discussed. Products under development, with applications ranging from softening blue jeans to producing life saving drugs, are examined. Throughout the emphasis is on market ...
|
more...
|
$1,850.00
|
|
European Therapeutic Monoclonal Antibody Markets
3/1/1998 | published by: Frost & Sullivan
... Including both the scientific and marketing points of view, the report provides a realistic overview of the market through 2003. Its forecasts highlight the market's potential in terms of incidence rates for the different indications ...
|
more...
|
$3,950.00
|
|
The Market for Cancer Therapeutics
4/1/1998 | published by: Kalorama Information
... restoration, and other emerging technologies. Find out about strategies companies are using to extend the life span of brand-name cancer therapeutic products that are coming off patent. Leading players are profiled. Individual sections are available.
|
more...
|
$2,437.50
|
|
The Market for Nutraceuticals
4/1/1998 | published by: Kalorama Information
... analyzes factors that promote growth; and examines the successful overseas markets. The study also assesses the impact of legislation on the market, and includes detailed discussions of the consumer environment. Other issues covered include: the ...
|
more...
|
$2,437.50
|
|
U.S., European, and Japanese Growth Hormone Markets
4/1/1998 | published by: Frost & Sullivan
... with product managers, major manufacturers, distributors, and physicians, includes population-based forecasts addressing such factors as prevalence, penetration, pricing, and growth. The report addresses key issues at length, providing insightful analysis of the tactics being successfully ...
|
more...
|
$2,950.00
|
|
Opportunities in Genomics and Associated High-Throughput Screening Markets
5/1/1998 | published by: Frost & Sullivan
... and beyond. This Frost & Sullivan report presents an exhaustive analysis of these exciting industries, including a discussion of new product developments, quality control issues, market challenges and opportunities, and profiles of key market participants.
|
more...
|
$3,450.00
|
|
Specialty Biocides Western Europe 1998
8/1/1998 | published by: Kline & Company, Inc.
... marketing information on grades and prices, applications, related consumption estimates, suppliers, market and regulatory trends, and forecasts to 2002. Fourteen end-use industrial and consumer applications are analyzed, providing information on biocide consumption and suppliers, channels ...
|
more...
|
$15,800.00
|
|
Bioinformatics in the Emerging Drug Discovery Marketplace
9/1/1998 | published by: Frost & Sullivan
... ensuring thorough coverage of all aspects of the emerging market. The study includes an assessment of market opportunities and positioning strategies, coverage of key competitive issues and technological trends, and profiles of key industry participants.
|
more...
|
$3,950.00
|
|
U.S. Research Biochemicals Markets
11/1/1998 | published by: Frost & Sullivan
... forecasts R&D spending by academic and nonprofit researchers, as well as by for-profit business. It also highlights crucial market trends and growth opportunities, presents sales and R&D strategies, and includes profiles of key industry participants.
|
more...
|
$3,450.00
|
|
European Absorbable and Erodible Biomaterials Markets
12/1/1998 | published by: Frost & Sullivan
... segment in eight European regional markets, this report offers a comprehensive guide to the future of the industry. This report monitors research trends, identifies new opportunities for growth, evaluates factors that will impact markets, and ...
|
more...
|
$3,950.00
|
|
Opportunities in the U.S. Neurogenomics Markets
12/1/1998 | published by: Frost & Sullivan
... on today's genomics deals in CNS. It analyzes the diseases that present the greatest revenue opportunity with an assessment of the major competitive issues and structure. With a careful examination of the challenges that face ...
|
more...
|
$3,450.00
|
|
U.S. Biomaterials Device Markets: HA and Collagen
2/1/1999 | published by: Frost & Sullivan
... product pricing, and unit sales. Identifying the key challenges facing the industry and strategies to succeed in light of obstacles, this report can give your company a head start on other market contenders. Procedure-based forecasts, ...
|
more...
|
$3,950.00
|


